Directa Plus Regulatory News (DCTA)

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

30 March 2026

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

Update on Funding

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets announces that it is in advanced discussions with an institutional investor for the provision of an up to £2.5m funding facility ("Proposed Facility") to extend the Company's cash runway. At this time there can be no certainty that any funding transaction will be concluded.

Further to the notification of 27 February 2026, the Company has not been able to conclude its discussions with Nant Capital, LLC with regards to the terms of a non-dilutive potential loan (the "Potential Loan").

The Proposed Facility would be subject to shareholder approval and if no additional funding is secured, it is highly likely that this will result in the Company and the Group not being a going concern and the Directors having to take steps to place the Company into administration.

As announced on 7 January 2026, the Group closed FY25 with gross cash balances of €1.5m (FY24: €4.98m), which provided an effective cash runaway into early May 2026 and therefore needed to secure additional funding in FY26 to support the business, hence the discussions regarding the Potential Loan and the Proposed Facility.

The Board is continuing to progress both the potential sale of non-strategic land held by its Romanian subsidiary Setcar SA, with an estimated value of at least €0.5m, as well as evaluating options for the business, including Setcar's disposal. The Board is continuing to implement the previously announced cost containment and cost reduction initiatives, including its workforce reduction programme at Setcar. The Italian company, Directa Plus SpA continues its costs reduction actions.

Further information will be provided in due course.

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

For further information, please contact:

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus's production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and past.

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus's products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

Directa Plus was established in 2005 and is based in Lomaz (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.